Cargando…
Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa–associated refractory pruritus
Autores principales: | LaMonica, Lauren C., Lang-Houser, Margaret, Bresler, Scott C., Mervak, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/ https://www.ncbi.nlm.nih.gov/pubmed/37456515 http://dx.doi.org/10.1016/j.jdcr.2023.06.012 |
Ejemplares similares
-
Familial Epidermolysis Bullosa Pruriginosa
por: Trivedi, Madhvi, et al.
Publicado: (2022) -
Epidermolysis bullosa pruriginosa responding to dupilumab
por: Clawson, Rebecca C., et al.
Publicado: (2021) -
Koebner's Phenomenon in Epidermolysis Bullosa Pruriginosa in an Infant
por: Pathania, Yashdeep S., et al.
Publicado: (2023) -
Epidermolysis bullosa pruriginosa: A report of two cases
por: Pai, Varadraj Vasant, et al.
Publicado: (2014) -
Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report
por: Wang, Zi, et al.
Publicado: (2021)